This article is visible for CLUB members only. If you are already a member but don’t see the content of this article, please login here. If you’re not a CLUB member yet, but you’d like to read members-only content like this one, have unrestricted access to the site and benefit from many additional perks, you The post Weekly funding round-up! All of the European startup funding rounds we tracked this week (Feb. 16-20) appeared first on EU-Startups.

Once upon a time, a company would build large, costly, and unwieldy satellites that would then be sent into orbit to sit, often for decades. Those satellites did their job, supporting navigation, tracking the weather, and enabling disaster response, as they circled the planet. These days, they do much more. They are crucial to modern The post The space race is being rewritten by AI – and Europe risks falling behind appeared first on EU-Startups.

Umlaut.bio, a German/Swiss oncology/immunology BioTech company developing tRNA-modifying small molecules, announced the extension of its pre-Seed financing to ~€3 million through the support of BaseLaunch. This addition not only helps to accelerate its science addressing tRNA modifications through the expertise of BaseLaunch but also highlights the potential of the approach through the approval by the The post Cancer and immunology player Umlaut.bio adds funding to reach ~€3 million pre-Seed total appeared first on EU-Startups.

The Vienna-based startup Lystio, an AI-native real estate portal, has closed a €500k funding round in order to expand with a focus on further developing their search algorithm and AI-powered features. In addition to Austrian investors, international business angels from Silicon Valley are participating, including an early Google employee. “We understood early on that distribution The post Austrian PropTech Lystio closes €500k round to refine real estate portal and expand across Europe appeared first on EU-Startups.

It is no secret by now that technological advances, especially artificial intelligence, have driven profound structural changes in healthcare. From the speed at which clinical tasks are executed to the precision that reduces human error, the industry is experiencing a long-awaited transformation. In oncology, these shifts are even more pronounced. We are diagnosing patients earlier, The post The next frontier in oncology: Why survival must become a designed metric, not a passive outcome appeared first on EU-Startups.

Rapidata, a Swiss company that accelerates AI development through scalable, on-demand data labeling via digital ads, announced a €7.2 million ($8.5 million) Seed round to scale their global human data network and support growing demand from AI companies that need faster, more reliable feedback to train, validate, and improve their models in an increasingly competitive The post Zurich-based AI infrastructure startup Rapidata raises €7.2 million to scale global human feedback network appeared first on EU-Startups.